|

January
22, 2003 Issue 139 From
the Editors Desk:
Formula
II Skin Care Cream Experience
Survey-
help your patients and help DIABETES IN CONTROL by participating in this
feedback study(no glucose readings required) Click
here for more information and how to participate.
Discussing erectile dysfunction
with your patients can be uncomfortable, use this weeks tool, the SHIM
TEST to make it easier. Click
here to review and print
This
weeks overview: Item
#3: Now 8% of Americans have Diabetes.
Item
#6 tells us that those with Type 1 diabetes are at greater
risk for Stroke and Heart Disease.
Item#9:
New Study shows those on metformin reduce their risk for death. Item#10:
Suggests new criteria for diagnosing Gestational Diabetes.
Dr.
Rosens, a protein
called Tissue Factor (TF) may be responsible for the clotting
reaction in the Edmonton Protocols and there is now a solution for it.
We
at DIABETES IN CONTROL are proud to have had our Christmas
article selected by the National
Institute of Diabetes and Digestive and Kidney Diseases (NIDDK),
Office of Scientific
Program and Policy Analysis
National Institutes of
Health (NIH) for
inclusion in a
publication that is a report on progress made since Congress provided
the HHS/NIH with special Congressional funds for type 1 diabetes
research. To
read this story click here.
Last
weeks “Test Your Knowledge” question had 75% with correct
answers. (According to AACE)
“Test
Your Knowledge” this week and see how you do?
Click
Here
Choice
Award Update:
The
winner of the Diabetes in Control Choice Award for the best new product
for the new millennium is…. Click
Here
to find out
The
winner of the scholarship will be announced on January 29th
Dave
Joffe, Editor-in-Chief
News
Flash - News Flash
Results
are in: ALLHATs off to the golden oldie--diuretics!
The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart
Attack Trial (ALLHAT) is one of the most important trials of
antihypertensive therapy. After
following the patients for around 5 years, the researchers found that the
diuretic was just as effective in preventing the primary end point (the
incidence of fatal coronary heart disease (CHD) or nonfatal heart attack) as
the other drugs. But in the prevention of secondary outcomes (all-cause
mortality, stroke, combined CHD or combined cardiovascular disease), better
results and a lower cost gave the diuretic the edge over its counterparts.
More Information

1.
New Test to Screen for Type 1 Diabetes Risk
Click
Here
2.
Bypass Surgery More Dangerous for Diabetic Patients
Click
Here
3.
New Survey Shows 8% of Americans Have Diabetes
Click
Here
4.
Proteinuria Quickens the Progression of Diabetic Nephropathy
Click
Here
5.
Less Frequent Eye Exams May Be Indicated for Some Diabetics
Click
Here
6.
Type 1 Diabetes Increases Stroke and Heart Disease Risk
Click
Here
7.
Tadalafil Safe and Effective in Impotent Diabetic Men
Click
Here
8.
Glipizide Controls Postbreakfast Hyperglycemia
Click
Here
9.
Metformin Linked to Reduced Risk of Mortality
Click
Here
10.
New Diagnostic Criteria For Gestational Diabetes
Click
Here
11.
Noninvasive Blood Glucose Monitor Getting Closer to Introduction
Click
Here
12.
African-Americans Unaware of Stroke Risks
Click
Here
13.
Repaglinide Affects Insulin Secretion and Oxidative Stress
Click
Here
14.
Adiponectin Levels Influence Type 2 Diabetes Risks
Click
Here
15.
Evidence For Denervation In Painful Neuropathy
Click
Here
Product
Update
A1cNow
is Now Over the Counter-No
Prescription Needed!
The first and only NGSP A1c test that is
instant and disposable. For more info on how you can now use it in your office
practice
Click Here!
75%
of patients with diabetes are not getting the recommended A1c testing!
To
order or for more information, click here. http://www.a1cnow.net

Packed
with Many Valuable Features... you'd
expect to pay over $2000.00 for a Website
Like This...
See
Examples, and Learn More.....>Click
Here
|